Steven Mickelsen

Chief Translational Science Officer at Acutus Medical

Dr. Steven Mickelsen currently serves as the Chief Translational Science Officer of Acutus Medical, guiding the innovation of the company’s access, diagnostics and therapy product portfolio, and brings more than a decade of experience in the development of breakthrough therapeutic medical devices. A board-certified electrophysiologist, Dr. Mickelsen spent ten years practicing at the University of Iowa Hospitals and Clinics in Iowa City, where he focused on complex ablation procedures and served as an Assistant Professor of Cardiovascular Medicine and Internal Medicine. In 2012, utilizing a pulsed electric field system that he invented, Dr. Mickelsen founded the company Farapulse to pursue more effective treatments for atrial fibrillation, a condition that affects as many as six million people nationwide. Dr. Mickelsen received his medical degree from the University of New Mexico School of Medicine and completed his internal medicine residency and clinical research at the Mayo Clinic. He also completed fellowships in Cardiology and Cardiac Electrophysiology at the University of Iowa Hospitals and Clinics and was a Howard Hughes research scholar at the National Institutes of Health.


  • Chief Translational Science Officer

    Current role

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.